ISOMORPHIC LABS
LIVE

Serial Number

79440662

Owner

Isomorphic Labs Limited

Attorney

Cynthia Walden

Filing Date

Sep 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ISOMORPHIC LABS Trademark

Serial Number: 79440662

ISOMORPHIC LABS is a trademark filed by Isomorphic Labs Limited on September 22, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Isomorphic Labs Limited (14 trademarks)

280 Bishopsgate
London EC2M4RB , GB

Entity Type: 99

Trademark Details

Filing Date

September 22, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of systemic inflammatory and immunological conditions; pharmaceutical preparations for the treatment of oncological and hematological diseases; pharmaceutical preparations for metabolic and endocrine disorders; pharmaceutical preparations for neurological diseases; and pharmaceutical preparations for infectious diseases

apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable computer software for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; blank digital and analogue recording storage media; downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software, computer programs and algorithms for use in manipulating received or inputted data generated in in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development

Scientific and technological services and research and design relating thereto in the field of medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; industrial analysis and industrial research services in the field medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; design and development of computer hardware and software; software as a service (saas) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; scientific research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; Providing online non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services provided in connection with the foregoing; computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds namely, medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; drug discovery services

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 22, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2026 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 1, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 1, 2026 COAR
REFUSAL PROCESSED BY IB
Mar 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 3, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 7, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 1, 2026 REPR